Asia Pacific Digital Diabetes Management Market Size & Outlook
Asia Pacific digital diabetes management market, 2018-2030 (US$M)
Related Markets
Asia Pacific digital diabetes management market highlights
- The Asia Pacific digital diabetes management market generated a revenue of USD 2,526.0 million in 2022.
- The market is expected to grow at a CAGR of 9.5% from 2023 to 2030.
- In terms of segment, continuous blood glucose monitoring system was the largest revenue generating product in 2022.
- Smart insulin pens is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 2,526.0 million |
| Market revenue in 2030 | USD 5,236.1 million |
| Growth rate | 9.5% (CAGR from 2022 to 2030) |
| Largest segment | Continuous blood glucose monitoring system |
| Fastest growing segment | Smart insulin pens |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Smart glucose meter, Continuous blood glucose monitoring system, Smart insulin pens, Smart insulin pumps, Apps |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.4% of the global digital diabetes management market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,236.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Diabetes Management Market Scope
Digital Diabetes Management Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific digital diabetes management market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital diabetes management market will help companies and investors design strategic landscapes.
Continuous blood glucose monitoring system was the largest segment with a revenue share of 40.72% in 2022. Horizon Databook has segmented the Asia Pacific digital diabetes management market based on smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, apps covering the revenue growth of each sub-segment from 2018 to 2030.
Its high growth rate can be primarily attributed to the high incidence of diabetes and an increase in product launches in countries such as China, India, and Japan. Several governments have undertaken initiatives to create awareness about diabetes among patients and physicians. The growing investments in development of digital diabetes management devices is expected to further propel the market.
Reasons to subscribe to Asia Pacific digital diabetes management market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific digital diabetes management market databook
-
Our clientele includes a mix of digital diabetes management market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific digital diabetes management market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific digital diabetes management market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific digital diabetes management market size, by country, 2018-2030 (US$M)
Asia Pacific Digital Diabetes Management Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
